Pediatrics
Credentials: Identifier: NPI 1801041157 · License: NC · License: VA
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy
Advances in Therapy · 2021
George Nomikos
1 paper
Leela Vrishabhendra
Yung Chyung